Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPOX | P50336 | 10/20 | 0.48 |
| ▸ | MEN1 | O00255 | 3/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.48 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.48 |
| ▸ | TTR | P02766 | 1/20 | 0.39 |
| ▸ | ALB | P02768 | 1/20 | 0.39 |
| ▸ | THRB | P10828 | 1/20 | 0.39 |
| ▸ | GRM8 | O00222 | 5/20 | 0.33 |
| ▸ | GRM4 | Q14833 | 5/20 | 0.33 |
| ▸ | GRM6 | O15303 | 3/20 | 0.33 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.32 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Aclonifen SCHEMBL7579895 | 0.91 | MEN1 (0.37) | PPOXMEN1KMT2ATDP1NR1I2 | |
| Oxadiazon SCHEMBL7580287 | 0.89 | PPOX (0.61) | PPOXMEN1KMT2ATDP1NR1I2 | |
| Oxadiazon SCHEMBL7580443 | 0.86 | PPOX (0.49) | PPOXMEN1KMT2ATDP1NR1I2 | |
| Oxadiazon SCHEMBL7586505 | 0.85 | PPOX (0.67) | PPOXMEN1KMT2ATDP1NR1I2 | |
| Oxadiazon SCHEMBL7582164 | 0.84 | PPOX (0.47) | PPOXMEN1KMT2ATDP1NR1I2 | |
| Oxadiazon SCHEMBL7581559 | 0.79 | PPOX (0.47) | PPOXMEN1KMT2ATDP1NR1I2 | |
| Aclonifen SCHEMBL7575878 | 0.79 | MEN1 (0.47) | PPOXMEN1KMT2ATDP1NR1I2 | |
| Oxadiazon SCHEMBL7578306 | 0.78 | PPOX (0.55) | PPOXMEN1KMT2ATDP1NR1I2 | |
| Mesotrione SCHEMBL7589370 | 0.78 | PPOX (0.45) | PPOXMEN1KMT2ATDP1NR1I2 | |
| Oxadiazon SCHEMBL7575892 | 0.77 | PPOX (0.49) | PPOXMEN1KMT2ATDP1NR1I2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20020004457-A1 | Herbicidal composition | SYNGENTA PARTICIPATIONS AG (CH) | 2002-01-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020004457-A1 | Herbicidal composition | PPOX, ALAD, DDT | PPOX 1/4885MEN1 4274/4885KMT2A 2099/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.